סקייריזי 600 מ"ג - Skyrizi 600 mg: הבדלים בין גרסאות

Skyrizi is indicated for the treatment of patients 16 years and older with moderately to severely active Crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy, or if such therapies are not advisable.